Head to head
Maximus vs Cintas
Side-by-side on the measures that matter, with a plain-English read. Full detail: MMS · CTAS
MMS
Maximus
62.79+1.27%
1-year price shape — -18% over the period
Quant Rating D · 24/100
vs
CTAS
Cintas
220.01+0.50%
1-year price shape — +21% over the period
Quant Rating C · 66/100
1-year performance, rebased to 100
Cintas edges it on the scoreable measures. Cintas has the highest Quant Rating (66); Cintas has done best over the past year (+21%).
| MMS | CTAS | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Business Services | Specialty Business Services |
| Last price | 62.79 | 220.01 |
| Change today | +1.27% | +0.50% |
| 1-year return | -18.0% | +21.0% |
| Market cap | $3.30B | $87.36B |
| 52-week range | 50.78 – 97.92 | 159.94 – 232.93 |
| Valuation | ||
| P/E (TTM) | 8.64 | 43.39 |
| P/E percentile, own 5-yr range | 10th | 65th |
| P/B | 1.80 | 16.79 |
| Dividend yield | 2.05% | 0.85% |
| Profitability & growth | ||
| EPS (TTM) | 7.27 | 4.91 |
| Net profit (TTM) | $382.00M | $1.95B |
| Revenue (TTM) | $5.25B | $11.56B |
| Provider revenue period date | 2026-06-29 | 2026-08-30 |
| Revenue growth (YoY) | -5.1% | +10.9% |
| Gross margin | 25.6% | 51.0% |
| Operating margin | 11.0% | 23.6% |
| Net margin | 7.1% | 17.8% |
| Free cash flow (TTM) | $433.23M | $2.03B |
| Provider cash-flow period date | 2026-06-29 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 110.0% | 69.3% |
| Insider activity (12mo) | 30 buy / 18 sell | 41 buy / 9 sell |
| Short interest (% of float) | 5.9% | 2.6% |
| Analyst consensus | -- | 64% buy / 29% hold / 7% sell (14) |
| Analyst price target | -- | $225 (+2%) |
| StockVane view | ||
| StockVane Quant Rating | D (24) | C (66) |
| Company | ||
| Employees | 37,200 | 48,100 |
| Founded | 1975 | 1968 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.